These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 34787486)

  • 1. Single-Point Mutations in the N Gene of SARS-CoV-2 Adversely Impact Detection by a Commercial Dual Target Diagnostic Assay.
    Miller S; Lee T; Merritt A; Pryce T; Levy A; Speers D
    Microbiol Spectr; 2021 Dec; 9(3):e0149421. PubMed ID: 34787486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    Lee J; Song JU
    J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Implementation of Improved SARS-CoV-2 Diagnostic Assays To Mitigate the Impact of Genomic Mutations on Target Failure: the Xpert Xpress SARS-CoV-2 Experience.
    Burns BL; Moody D; Tu ZJ; Nakitandwe J; Brock JE; Bosler D; Mitchell SL; Loeffelholz MJ; Rhoads DD
    Microbiol Spectr; 2022 Dec; 10(6):e0135522. PubMed ID: 36255326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
    Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
    J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability.
    Foster CSP; Madden M; Chan R; Agapiou D; Bull RA; Rawlinson WD; Van Hal SJ
    Pathology; 2022 Jun; 54(4):499-501. PubMed ID: 35440368
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States.
    Leelawong M; Mitchell SL; Fowler RC; Gonzalez E; Hughes S; Griffith MP; Marsh JW; Harrison LH; Rakeman JL
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115468. PubMed ID: 34425451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant.
    Choi H; Hwang M; Lukey J; Jinadatha C; Navarathna DH
    Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115699. PubMed ID: 35569431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman.
    Al-Kindi N; Al-Shukri I; Al-Rashdi A; Al-Siyabi N; Al Mahruqi S; Al-Kindi H; Al-Jardani A
    Pan Afr Med J; 2021; 40():2. PubMed ID: 34650652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada.
    Isabel S; Abdulnoor M; Boissinot K; Isabel MR; de Borja R; Zuzarte PC; Sjaarda CP; R Barker K; Sheth PM; Matukas LM; Gubbay JB; McGeer AJ; Mubareka S; Simpson JT; Fattouh R
    Sci Rep; 2022 Jun; 12(1):10867. PubMed ID: 35760824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection clusters can elevate risk of diagnostic target failure for detection of SARS-CoV-2.
    Lopez D; Roberts J; Bourgeois M; Kootstra J; Minnick S; Black A; Mauss J; Flores N
    PLoS One; 2022; 17(2):e0264008. PubMed ID: 35171960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.
    Craney A; Petrik D; Suhku A; Qiu Y; Racine-Brzostek S; Rennert H; Piscatelli H; Rathnaiah G; Hangman A; Carrie M; Cushing M
    Microbiol Spectr; 2021 Sep; 9(1):e0008321. PubMed ID: 34378961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocapsid single point-mutation associated with drop-out on RT-PCR assay for SARS-CoV-2 detection.
    de Mello Malta F; Amgarten D; Marra AR; Petroni RC; da Silva Nali LH; Siqueira RA; Neto MC; Oler SC; Pinho JRR
    BMC Infect Dis; 2023 Oct; 23(1):714. PubMed ID: 37872472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.
    Kami W; Kinjo T; Hashioka H; Arakaki W; Uechi K; Takahashi A; Oki H; Tanaka K; Motooka D; Nakamura S; Nakamatsu M; Maeda S; Yamamoto K; Fujita J
    J Virol Methods; 2023 Apr; 314():114692. PubMed ID: 36796678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and comparison of novel multiple cross displacement amplification (MCDA) assays with other nucleic acid amplification methods for SARS-CoV-2 detection.
    Luu LDW; Payne M; Zhang X; Luo L; Lan R
    Sci Rep; 2021 Jan; 11(1):1873. PubMed ID: 33479389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, evaluation of the PNA RT-LAMP assay for rapid molecular detection of SARS-CoV-2.
    Bat-Ochir C; Kim YS; Kim HG; Lee SS; Lee HW; Park HK
    Sci Rep; 2021 Oct; 11(1):20471. PubMed ID: 34650067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results.
    Lesbon JCC; Poleti MD; de Mattos Oliveira EC; Patané JSL; Clemente LG; Viala VL; Ribeiro G; Giovanetti M; de Alcantara LCJ; Teixeira O; Nonato MC; de Lima LPO; Martins AJ; Dos Santos Barros CR; Marqueze EC; de Souza Todão Bernardino J; Moretti DB; Brassaloti RA; de Lello Rocha Campos Cassano R; Mariani PDSC; Slavov SN; Dos Santos RB; Rodrigues ES; Santos EV; Borges JS; de La Roque DGL; Kitajima JP; Santos B; Assato PA; da Silva da Costa FA; Banho CA; Sacchetto L; Moraes MM; Palmieri M; da Silva FEV; Grotto RMT; Souza-Neto JA; Nogueira ML; Coutinho LL; Calado RT; Neto RM; Covas DT; Kashima S; Elias MC; Sampaio SC; Fukumasu H
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.